Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

Barnett, Anthony; C. Bain, Stephen; Bouter, Paul; E. Karlberg, Bengt; Madsbad, Sten; Jervell, J; Mustonen, Jukka

doi:10.1056/nejmoa042274

Public

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

Published in New England Journal of Medicine • Oct 31, 2004

Authors:

Anthony Barnett

Stephen C. Bain

Paul Bouter

Abstract

BACKGROUND: Few studies have directly compared the renoprotective effects of angiotensin II-receptor blockers and angiotensin-converting-enzyme (ACE) inhibitors in persons with type 2 diabetes. METHODS: In this prospective, multicenter, double-blind, five-year study, we randomly assigned 250 subject...

Subject

Medicine

Blockade

Nephropathy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!